Both Holst and Sattar pointed to a discontinued GLP-1 drug once marketed by GSK, albiglutide ... says the drug is quite similar in structure to exenatide, making it hard to explain why a trio ...

Both Holst and Sattar pointed to a discontinued GLP-1 drug once marketed by GSK, albiglutide ... says the drug is quite similar in structure to exenatide, making it hard to explain why a trio ...

Coronary artery disease is the leading cause of death worldwide. It imposes an enormous symptomatic burden on patients, leaving many with residual disease despite optimal procedural therapy and up to ...

A model showing how metallic bonds are formed - the first diagram shows the outer electrons in their atoms, and the second diagram shows that the electrons have become delocalised ...

Its ability to identify subtle changes in cardiac structure and function underscores its role as the gold standard imaging modality in this patient population. However, this technique is not without ...

Check out the nestjs-project-performance repository for examples using this alternative.